MedPath

A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis

Conditions
Breast Cancer Diagnosis
Breast Cancer Screening
Interventions
Diagnostic Test: mammography and ultrasound screening
Registration Number
NCT04429269
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

Improving the early diagnosis of breast cancer can reduce mortality. With mammography as the main tool for screening early breast cancer, the characteristics of dense breast and young onset of disease in Chinese women lowers the efficiency. The aim of this prospective study was to compare which method, x-ray or ultrasound, is more appropriate for screening and early diagnosis of breast cancer in Chinese women.

Detailed Description

Breast cancer has become the most common malignancy in women. Improving the early diagnosis of breast cancer can reduce mortality. Mammography is recommended as the main tool for screening and early diagnosis of breast cancer in the guidelines of European and American countries. However, the characteristics of dense breast and young onset of disease in Chinese women make the screening and early diagnosis strategies of Western countries, which are mainly based on mammography, unsuitable for Chinese women. The aim of this prospective study was to compare which method, x-ray or ultrasound, is more appropriate for screening and early diagnosis of breast cancer in Chinese women.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
6000
Inclusion Criteria
  • Informed consent, subjects 35-70 years old, asymptomatic, able to undergo ultrasound and x-ray
Exclusion Criteria
  • Localized breast erythema and ulceration, pregnancy, lactation, after previous breast implantation, already pathologically definite breast cancer patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
mammography and ultrasoundmammography and ultrasound screeningmammography and ultrasound screening
Primary Outcome Measures
NameTimeMethod
screening yield3 years

The sensitivity, specificity, positive predictive value, and negative predictive value of the screening methods.

Secondary Outcome Measures
NameTimeMethod
cost-effectiveness3 years

The cost-effectiveness of each screening modality to detect one case of breast cancer

Trial Locations

Locations (1)

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath